Health IT mistakes can hurt patient safety
Study results link EHRs to serious adverse events in medical malpractice cases
Study results link EHRs to serious adverse events in medical malpractice cases
Changing patterns in IT spending at facilities such as Beth Israel Deaconess Medical Center suggest hospitals are entering a 'post-EHR era,' says its CIO, John Halamka, MD (left).
New data shows the number of health breaches rising quickly
As providers change IT strategies to embrace the use of the cloud, Epic finds rising demand for hosted applications.
With the future of meaningful use unclear, the path to value-based care uncertain, and the trend to more modular components, EHR and other software vendors re-evaluate their product development plans.
Athenahealth, eClinicalWorks, Epic, NextGen Healthcare and Surescripts aim to improve the exchange of health data.
Personalized patient care is at least five years away for a majority of those responding to a new survey.
While organizations with vast electronic health record experience are showing positive results, others wonder when they'll achieve measurable benefits.
Despite a tremendous push, people still aren’t viewing their medical information online. An overhaul of technology infrastructure and culture is in order, which creates another challenge for chief information officers and other HIT executives.
After months of bipartisan work, the Senate health committee has released for public comment draft legislation designed to help improve functionality and interoperability of electronic health records systems, and ease patient access to their healthcare data.
News of the demise of the Meaningful Use program — including Stage 3 — has been greatly exaggerated, according to Karen DeSalvo, MD, National Coordinator for Health Information Technology, who spoke Wednesday morning at a joint HIT Policy and Standards Committee meeting.
The National Institutes of Health will spend $280 million over four years to fund a set of genome sequencing and analysis centers to better understand the genomic basis for both common and rare human diseases with the goal of improved diagnosis and potential treatments.